Michael Goller

Director/Board Member at DBV TECHNOLOGIES

Net worth: - $ as of 31/05/2026

51 year

78 connections

Health Technology

Finance

Consumer Services

Profile

Michael J.
Goller is currently a Director at DBV Technologies SA since 2015, a Director at Terremoto Biosciences, Inc., an Independent Director at Replimune Group, Inc. starting in 2025, and a Partner at Baker Bros.
Advisors LP since 2005.
Former roles include Director at diaDexus, Inc. from 2005 to 2010, Director at Levo Therapeutics, Inc. from 2017 to 2019, Independent Non-Executive Director at BeOne Medicines Ltd. from 2015 to 2026, Associate at J.P.
Morgan Partners LLC from 1993 to 2003, and Investment Banker at Merrill Lynch & Co., Inc. from 1997 to 1999.
Education includes graduate and Masters of Business Administration degrees from The Wharton School of the University of Pennsylvania and an undergraduate degree from The Pennsylvania State University conferred in 1997.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BEONE MEDICINES LTD. -.--%	11/06/2026	0 ( -.--% )	- $	31/05/2026
DBV TECHNOLOGIES SA -.--%	15/04/2026	0 ( -.--% )	- $	31/05/2026

Michael Goller active positions

Companies	Position	Start
DBV TECHNOLOGIES	Director/Board Member	21/10/2015
REPLIMUNE GROUP, INC.	Director/Board Member	05/03/2025
Baker Bros. Advisors LP Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities.	Analyst-Equity	01/01/2005
Terremoto Biosciences, Inc. Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases	Director/Board Member	-

All active positions of Michael Goller

Former positions of Michael Goller

Companies	Position	End
BEIGENE LTD	Director/Board Member	11/06/2026
Levo Therapeutics, Inc. Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics	Director/Board Member	01/02/2019
diaDexus, Inc. /Old/ diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets diagnostic products	Director/Board Member	01/11/2010
J.P. Morgan Partners LLC J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners provides financing for growth capital, corporate acquisitions, LBOs, special situations and recapitalizations. The firm invests globally across a variety of sectors including consumer, media, energy, industrial, financial services, healthcare and technology	Corporate Officer/Principal	01/01/2003
Merrill Lynch & Co., Inc. Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services	Corporate Officer/Principal	01/01/1999

See the detail of Michael Goller's experience

Training of Michael Goller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Goller's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
diaDexus, Inc. /Old/ diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets diagnostic products	Health Technology
Baker Bros. Advisors LP Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities.	Finance
J.P. Morgan Partners LLC J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners provides financing for growth capital, corporate acquisitions, LBOs, special situations and recapitalizations. The firm invests globally across a variety of sectors including consumer, media, energy, industrial, financial services, healthcare and technology	Finance
The Pennsylvania State University The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
DBV Technologies SA DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy	Health Technology
Merrill Lynch & Co., Inc. Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services	Finance
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Replimune Group, Inc. Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies	Health Technology
BeiGene Ltd. BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Health Technology
Levo Therapeutics, Inc. Levo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research into therapeutics	Health Technology
Terremoto Biosciences, Inc. Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases	Health Technology